We’re presenting at the 2nd Annual Meeting of the Society for mRNA Medicines
We’re proud to announce that we’ll be attending the 2nd Annual Meeting of the Society for mRNA Medicines, in Coronado (CA) from September 16–18, 2025.
read moreWe’re proud to announce that we’ll be attending the 2nd Annual Meeting of the Society for mRNA Medicines, in Coronado (CA) from September 16–18, 2025.
read moreWe’re thrilled to announce that our team will participate in RNA Leaders USA 2025, taking place in Boston on September 10-11
read moreWe are excited to announce that our team will be attending Advanced Therapies Europe 2025 in Barcelona, 2-4 September 2025.
read moreFrom July 21st to 23rd, 2025, Boston will host one of the most influential gatherings in the field of mRNA innovation: the mRNA-Based Therapeutics Summit USA.
read moreWe’re among the Alliance for Regenerative Medicine (ARM) leaders calling on the EU to act for the future of advanced therapies in Europe.
read moreWe’re excited to announce our participation in the BIO International Convention 2025, taking place from June 16–19 at the Boston Convention & Exhibition Center.
read moreWe are thrilled to announce our participation in the 64th AFI Symposium, taking place from June 11 to 13, 2025, at the Palacongressi di Rimini.
read moreAnemocyte, a biotech company at the forefront of advanced therapy development, is excited to join the upcoming international conference on gene therapy in Gaithersburg, MD.
read more
Altheia Science proudly announces the success of its strategic collaboration with Anemocyte, a leading developer and manufacturer of pDNA and mRNA headquartered in Italy.
read moreGenenta and Anemocyte announce a collaboration for the manufacturing of starting materials for cutting-edge cell based therapies
read more